PlexusDx personalized semaglutide therapy starts at low dosestypically 0.25 mg weeklyallowing your stomach and esophagus to adjust gradually
Starting at $ 499 / Month GIP + GLP-1 receptor agonist that is FDA-approved for chronice weight management Zepbound Adults with obesity (BMI 30) or overweight (BMI 27 with a related health condition) Start TodayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
This science is in research mode only right now
For the fatigue factor, we have used nitric oxide boosting preparations of beetroot, and in patients older than 40 years of age, precursors to nitric oxide, such as L-citrulline and L-arginine